Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial

@inproceedings{Devroe2015SafetyAF,
  title={Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial},
  author={Sarah Devroe and Jurgen Lemiere and Marc van de Velde and Marc Gewillig and Derize Elizabeth Boshoff and S. Rex},
  booktitle={Trials},
  year={2015}
}
BACKGROUND Xenon has minimal haemodynamic side effects when compared to volatile or intravenous anaesthetics. Moreover, in in vitro and in animal experiments, xenon has been demonstrated to convey cardio- and neuroprotective effects. Neuroprotection could be advantageous in paediatric anaesthesia as there is growing concern, based on both laboratory studies… CONTINUE READING